Measure
Resolve cell state across time and tissue geography.
We uncover how developmental history and tumor geography shape T-cell fate—then use those insights to engineer durable cellular immunotherapies.

Perelman School of Medicine · University of Pennsylvania
History shapes a therapeutic T cell. Tissue geography tests it. Causal mechanism reveals where intervention is possible—and engineering turns that knowledge into a new cellular instruction.




Resolve cell state across time and tissue geography.
Convert association into causal molecular mechanism.
Convert mechanism into therapeutic instructions.
A therapeutic T cell carries a history. Its fate begins during manufacture, then collides with the metabolic and signaling geography of a tumor. We study both—and the causal links between them.

We use temporal CRISPR screens, perturbation-based lineage tracing, and multi-omic profiling to find the formative windows when metabolic and epigenetic cues can bias T cells toward durable immunity.
Which formative signals preserve a T cell's capacity for durable function before it ever sees a tumor?

We resolve suppressive cell neighborhoods and metabolic gradients in pancreatic tumors, then perturb those interactions in vivo to reveal which spatial niches drive therapeutic T-cell dysfunction.
Which tumor neighborhoods impose irreversible dysfunction—and which still offer a window for rescue?
We convert mechanistic insight into living medicines: synthetic receptors that turn suppressive signals into activation, metabolic programs that preserve stemness, and proteostasis circuits that resist exhaustion.

The lab operates across wet-lab immunology, quantitative biology, and cell engineering. We do not stop at molecular maps: every model is a hypothesis generator, and every candidate mechanism is tested in cells and tissues.
See where you could contributeFlagship scholarship, competitive support, trainee trajectories, and public reach—selected signals from a program built to connect discovery with consequence.
First / co-first author
02First / co-first + corresponding
03First author
04Co-first author
Photo: STAT WunderkindsSystems immunologist · Cell engineer · Quantitative biologist
Yapeng Su is launching the Su Lab in the Department of Pathology and Laboratory Medicine at Penn’s Perelman School of Medicine. He studies how T cells make fate decisions across space and time, combining molecular mechanism, single-cell and spatial measurement, quantitative modeling, and therapeutic engineering to design more durable TCR-T cells for solid tumors.
We pursue ambitious, high-impact science in a fast-moving training environment built on discipline, rigor, direct feedback, and generous teamwork. The standard is high—and so is our investment in each person's growth and next career stage.
Founding members help establish the experimental systems, analytical standards, and scientific language of the laboratory.
Early projects are designed for genuine intellectual ownership at the intersection of immunology, spatial biology, and cell engineering.
Direct PI mentorship, fast feedback, cross-disciplinary fluency, and deliberate career preparation are built into the lab’s operating model.